0001127602-20-024227.txt : 20200825
0001127602-20-024227.hdr.sgml : 20200825
20200825165535
ACCESSION NUMBER: 0001127602-20-024227
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200824
FILED AS OF DATE: 20200825
DATE AS OF CHANGE: 20200825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoge Stephen
CENTRAL INDEX KEY: 0001760669
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 201132887
MAIL ADDRESS:
STREET 1: C/O MODERNA, INC.
STREET 2: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-08-24
0001682852
Moderna, Inc.
MRNA
0001760669
Hoge Stephen
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
President
Common Stock
2020-08-24
4
M
0
10000
.99
A
1966530
D
Common Stock
2020-08-24
4
S
0
2636
63.65
D
1963894
D
Common Stock
2020-08-24
4
S
0
7489
64.53
D
1956405
D
Common Stock
2020-08-24
4
S
0
7079
65.31
D
1949326
D
Common Stock
2020-08-24
4
S
0
1996
66.38
D
1947330
D
Common Stock
2020-08-24
4
S
0
800
67.29
D
1946530
D
Common Stock
4116
I
By Valhalla, LLC
Stock Option (Right to Buy)
.99
2020-08-24
4
M
0
10000
0
D
2023-08-19
Common Stock
10000
837431
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.93 to $63.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.97 to $64.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.98 to $65.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.99 to $66.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.12 to $67.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This option is fully vested and exercisable.
/s/ Lori Henderson, as Attorney-in-Fact
2020-08-25